Background-Mutations in the cardiac Na ϩ channel gene (SCN5A) can adversely affect electric function in the heart, but effects can be age dependent. We explored the interacting effects of Scn5a disruption and aging on the pathogenesis of sinus node dysfunction in a heterozygous Scn5a knockout (Scn5a ϩ/Ϫ ) mouse model. Methods and Results-We compared functional, histological, and molecular features in young (3 to 4 month) and old (1 year) wild type and Scn5a ϩ/Ϫ mice. Both Scn5a disruption and aging were associated with decreased heart rate variability, reduced sinoatrial node automaticity, and slowed sinoatrial conduction. They also led to increased collagen and fibroblast levels and upregulated transforming growth factor-␤ 1 (TGF-␤ 1 ) and vimentin transcripts, providing measures of fibrosis and reduced Nav1.5 expression. All these effects were most noticeable in old Scn5a ϩ/Ϫ mice. Na ϩ channel inhibition by Nav1.5-E3 antibody directly increased TGF-␤ 1 production in both cultured human cardiac myocytes and fibroblasts. Finally, aging was associated with downregulation of a wide range of ion channel and related transcripts and, again, was greatest in old Scn5a ϩ/Ϫ mice. The quantitative results from these studies permitted computer simulations that successfully replicated the observed sinoatrial node phenotypes shown by the different experimental groups. Conclusions-These results implicate a tissue degeneration triggered by Nav1.5 deficiency manifesting as a TGF-␤ 1mediated fibrosis accompanied by electric remodeling in the sinus node dysfunction associated with Scn5a disruption or aging. The latter effects interact to produce the most severe phenotype in old Scn5a ϩ/Ϫ mice. In demonstrating this, our findings suggest a novel regulatory role for Nav1.5 in cellular biological processes in addition to its electrophysiologic function. (Circ Arrhythm Electrophysiol. 2011;4:397-406.)
S inus node dysfunction (SND) is associated with abnormal impulse formation and propagation in the sinoatrial node (SAN). It presents clinically as sinus bradycardia, sinus pause or arrest, atrial chronotropic incompetence, and SAN exit block. 1 It affects Ϸ1 in 600 cardiac patients aged Ͼ65 years and is responsible for Ϸ50% of the 1 million permanent pacemaker implants per year worldwide. 2, 3 Although SND occurs most commonly in elderly patients in the absence of clinically apparent accompanying cardiac disease, 2 its pathogenesis is unclear. Nevertheless, experimental animal models do show structural, electrophysiological, and ion channel remodeling with age. 2,4 -7 Furthermore, genetic defects in ion channels that include those involving human Nav1.5 have been associated with familial sick sinus syndrome, a rare congenital form of SND. 8 -10 Finally, genetic defects in SCN5A also are associated with progressive (ie, agedependent) cardiac conduction disease (PCCD), which often is accompanied by SND. 10, 11 Clinical Perspective on p 406
The clinical severity of such arrhythmic syndromes among SCN5A mutation carriers varies with genetic background, the presence or absence of molecular modifiers, and particular physiological conditions. Of these factors, age appears to be the most important influence. Thus, slowed conduction in PCCD progressively worsens with age, ultimately leading to an atrioventricular block requiring pacemaker implantation. 11 Several familial arrhythmic syndromes associated with SCN5A show degenerative fibrotic cardiac abnormalities to extents that vary with age, 10, 12, 13 but it is uncertain whether this acts through the resulting phenotype or directly participates in the pathogenic process itself.
The recently developed heterozygous Scn5a knockout (Scn5a ϩ/Ϫ ) mouse model shows a 50% background haploinsufficiency in the wild-type (WT) Nav1.5 protein. 14 In common with human PCCD, [15] [16] [17] it shows cardiac conduction slowing with a pattern consistent with age-dependent degenerative cardiac abnormalities. Scn5a ϩ/Ϫ mice also show sinus bradycardia, slowed SAN conduction, and SAN exit block, replicating major features of clinically observed SND in patients. 18 Scn5a ϩ/Ϫ mice also have been reported to display great variability in their electrophysiological phenotype. In fact, there may even be 2 distinct phenotypes-a milder one and a more severe one-the difference being associated with the level of myocardial remodeling, aging, and functional Nav1.5 protein. [15] [16] [17] The present study accordingly uses this model in an investigation of interactions between aging and Scn5a disruption in producing SND and the possible cellular and molecular mechanisms that produce this condition.
Methods
The methods are described briefly herein, with full accounts provided in the online-only Data Supplement.
Animals
All experiments conformed to the UK Animal (Scientific Procedures) Act (1986). Heterozygous Scn5a ϩ/Ϫ mice were generated as previously described. 14 Four groups of mice were used: young WT and young Scn5a ϩ/Ϫ mice (aged 3 to 4 months) and old WT and old Scn5a ϩ/Ϫ mice (aged Ն12 months, equivalent to a 3-year-old rat and a 60-to 65-year-old human).
Electrophysiological Studies in Anesthetized Animals
Surface ECG recordings were made using a Powerlab 26T system (ADInstruments; Oxford, UK) and Chart version 6.0. Corrected SAN recovery time was measured by an esophageal pacing protocol. Heart rate variability (HRV) was examined and presented as Poincaré plots.
Electrophysiological Studies in Isolated SAN Tissue Preparations
Multielectrode array recordings of extracellular potentials (onlineonly Data Supplement Figure 1 ) applied to isolated SAN preparations permitted construction of SAN activation maps and measurements of SAN cycle length (CL) and sinoatrial conduction time (SACT) as described previously. 18
Histology and Immunohistochemistry
Selected SAN regions were first identified by anti-HCN4 immunostaining. The adjacent sections were used for either picrosirius red collagen staining or vimentin fibroblast immunostaining.
RNA Isolation and Real-Time Polymerase Chain Reaction
Total RNA was extracted from frozen SANs using an RNeasy Micro Kit (Qiagen), and cDNA was synthesized using the Superscript III First Strand Synthesis System (Invitrogen). Random hexamers were chosen as the primer. Real-time polymerase chain reaction was performed using either the Taqman or SYBR green systems (Applied Biosystems). The mRNA levels of each gene were normalized to HPRT levels.
Nav1.5-E3 Antibody Treatment of Human Neonatal Cardiac Myocytes and Fibroblasts
Transforming growth factor-␤ 1 (TGF-␤ 1 ) was detected at transcriptional and protein levels in cultured human neonatal cardiac myocytes and fibroblasts after 24 hours of treatment with Nav1.5-E3 antibody. 19 
Patch Clamping of Cultured Human Neonatal Cardiac Myocytes
Fast inward Na current (i Na ) was recorded by voltage clamping to compare cells with and without treatment of Nav1.5-E3 antibody for 24 hours.
Computer Simulations
Computer simulations of electrophysiological function in SAN cells used RNA levels of the individual ion channels in the different groups derived from real-time polymerase chain reaction (onlineonly Data Supplement Table 1 ). They simulated the pacemaking CLs of the SAN cells and the conduction times between the SAN and the atrium (measured as the time delay between the excitation of the SAN and the atrial cells). The starting point was a recently developed mathematical mouse SAN cell model. 20
Statistical Analysis
The experiments were designed to examine both the main effect of the 2 factors Nav1.5 deficiency and age as an outcome that shows consistent differences between levels of a factor (age or Nav1.5 deficiency) and the interaction between these 2 factors; namely, an interaction effect is said to exist when differences in 1 factor depend on the level of the other factor. These effects were analyzed by a 2-way factorial ANOVA, namely, the effects of Scn5a disruption (WT versus Scn5a ϩ/Ϫ ), aging (young versus old), and interactions between these. All values are presented as meanϮSEM. Student t test was used in experiments involving Nav1.5-E3 antibody treatment on human neonatal cardiac myocytes and fibroblasts. Nonlinear and linear regression studies were performed to investigate correlations between parameters. PϽ0.05 was considered to indicate significant differences.
Results

Electrocardiographic Characteristics
SAN automaticity was first characterized through electrocardiographic recordings and esophageal electric pacing in anesthetized mice. Figure 1 shows typical electrocardiographic recordings illustrating slower heart rates in Scn5a ϩ/Ϫ compared with WT mice ( Figure 1A , top 2 traces). The occasional young (2 of 11) and old Scn5a ϩ/Ϫ (1 of 10) mice, but none of the young (0 of 19) or old WT (0 of 10) mice, showed more extreme manifestations of SAN malfunction in the form of sinus pause/arrest or atrioventricular conduction block ( Figure 1A , bottom 2 traces). Online-only Data Supplement Table 2 correlates longer P-wave durations and longer PR, QRS, and QTc intervals with Scn5a disruption but not age. Corrected SAN recovery time after esophageal pacing also increased with the Scn5a disruption ( Figure 1B and 1C, online-only Data Supplement Table 2 ) but not with age. Nevertheless, Poincaré plots between each RR interval and its immediately preceding RR interval showed reduced scatter with both aging and Scn5a disruption, with old Scn5a ϩ/Ϫ mice producing the tightest cluster ( Figure 2A ). Such findings suggest a decreased HRV consistent with alterations in autonomic modulation. These findings were quantified as the standard deviation of the change in RR intervals obtained from the differences between consecutive pairs of RR intervals, revealing significant differences in both Scn5a disruption and aging and the greatest reduction in the combined condition ( Figure 2B ).
Mapping of Impulse Generation and Conduction in Isolated SAN Preparations
The detailed intrinsic electric properties of the SAN were then characterized by multielectrode array recordings of extracellular potentials from SAN preparations (online-only Data Supplement Figure 1 ) isolated from their autonomic inputs. Activation at each recording site gave detectable, often biphasic, electrogram deflections from which intrinsic CL and SACT can be determined. The primary pacemaker region was determined by the earliest deflection in the array (starred traces). The left side of Figure 3A ). Furthermore, these effects interacted to produce the greatest functional changes in the old Scn5a ϩ/Ϫ hearts (CL Scn5a ϩ/Ϫ versus WT, Pϭ0.005; CL old versus young, PϽ0.001; SACT Scn5a ϩ/Ϫ versus WT, PϽ0.001; SACT old versus young, PϽ0.001; interaction of the 2 effects, Pϭ0.04). Thus, there was a decreased SAN automaticity and slower conduction (within SAN and from SAN to surrounding atrium) in Scn5a ϩ/Ϫ compared to WT mice and in old compared to young mice, with the old Scn5a ϩ/Ϫ mice showing the slowest automaticity and the slowest conduction.
Interstitial Fibrosis in the SAN
To determine whether these physiological changes associated with aging and Scn5a disruption were accompanied by degenerative structural abnormalities in the SAN, we examined their corresponding abundances of collagen and fibroblasts, the main interstitial components. The SAN regions selected for the study were identified by HCN4 staining (online-only Data Supplement Figure 2 ). The adjacent sec- Heart rate variability analysis Poincaré plot from surface ECG recorded from anesthetized mice. Top four panels, Poincaré plot pattern types in young WT, young Scn5a ϩ/Ϫ , old WT, and old Scn5a ϩ/Ϫ mice. The duration of each normalized (normalized by mean cycle length) RRn was plotted against that of its immediately preceding normalized RRn (RRnϩ1). Bottom panel, SD of ⌬RR intervals: 1 normalized RRn was subtracted by the immediately following RRnϩ1 (young WT, nϭ19; young Scn5a ϩ/Ϫ , nϭ9; old WT, nϭ10; old Scn5a ϩ/Ϫ , nϭ9). Two-way ANOVA Pϭ0.03 for Scn5a ϩ/Ϫ versus WT mice and Pϭ0.018 for old versus young mice. Aging and Scn5a disruption interaction, Pϭ0.03. RRn indicates RR interval. Other abbreviations as in Figure 1 .
tions then were used for either picrosirius red or vimentin immunostaining. The picrosirius red staining associated both aging and Scn5a disruption with increased collagen abundance (dark red) in the SAN area (Scn5a ϩ/Ϫ versus WT, Pϭ0.002; old versus young, Pϭ0.04) ( Figure 4A and 4C ). Vimentin immunostaining then demonstrated parallel increases in fibroblast density (green) in the SAN area (Scn5a ϩ/Ϫ versus WT, Pϭ0.017; old versus young, PϽ0.001) ( Figure 4B and 4D). In both cases, the greatest effects occurred in the old Scn5a ϩ/Ϫ hearts.
Alterations in Transcripts of Fibrotic Regulatory Genes
These tissue fibrotic changes were accompanied by alterations in fibrotic regulatory transcripts. Aging and Scn5a disruption both upregulated transcription of the major fibrosis cytokine TGF-␤ 1 and the fibroblast marker vimentin in the SAN. Again, the greatest effects were in the old Scn5a ϩ/Ϫ mice (TGF-␤ 1 Scn5a ϩ/Ϫ versus WT, Pϭ0.005; TGF-␤ 1 old versus young, Pϭ0.005; interaction between the 2 effects, Pϭ0.02; vimentin Scn5a ϩ/Ϫ versus WT, Pϭ0.008; vimentin old versus young, Pϭ0.001; interaction between the 2 effects, Pϭ0.003) ( Figure 5A ). Both aging and Scn5a disruption were associated with a significant downregulation of Nav1.5 expression (Scn5a ϩ/Ϫ versus WT, Pϭ0.02; old versus young, Pϭ0.005) ( Figure 5A ) to give the following sequence of falling Nav1.5 expression: young WTϾyoung Scn5a ϩ/Ϫ Ͼold WTϾold Scn5a ϩ/Ϫ . There was a surprisingly significant nonlinear negative regression between both TGF-␤ 1 and vimentin and Nav1.5 expression (TGF-␤ 1 , R 2 ϭ0.77, PϽ0.001; vimentin, R 2 ϭ0.78, PϽ0.001) ( Figure 5B ) as well as a less surprising linear correlation between vimentin and TGF-␤ 1 expression (R 2 ϭ0.85, PϽ0.001) ( Figure 5B ).
The surprising correlation between Nav1.5 and fibrotic genes then prompted direct tests of the hypothesis that reduced Nav1.5 channel expression or activity might acutely upregulate TGF-␤ 1 and vimentin transcripts in cardiac myocytes and cardiac fibroblasts, both known to express Nav1.5. 21 Twenty-four-hour incubations with 15 g/mL Nav1.5-E3 antibody, known specifically to inhibit Nav1.5 function, 19 produced 0.9-and 1.2-fold upregulations of TGF-␤ 1 transcript in cardiac myocytes and fibroblasts, respectively, and 18-and 4.6-fold increases in active TGF-␤ 1 protein in the cell culture medium (antibody treatment versus control for either myocytes or fibroblasts, Pϭ0.04 for transcripts of myoctes, Pϭ0.03 for transcripts of fibroblasts, and PϽ0.001 for protein) ( Figure 5C ). As shown in online-only Data Supplement Figure 3 , such increased TGF-␤ 1 mRNA/ active form TGF-␤ 1 protein in myocytes treated with Nav1.5-E3 antibody is associated with an Ϸ20% reduction in Nav1.5 protein expression and an Ϸ50% reduction in peak i Na current density compared to nontreated cells. Nav1.5 mRNA expression in these myocytes, however, remained unchanged (data not shown).
Remodeling in Transcription of Ion Channel Genes
We then investigated the effects of either aging or Scn5a disruption on transcriptional levels of 85 ion channel and regulatory genes in the SAN. Figure 6 and online-only Data Supplement Table 3 list the genes showing statistically significant changes in relationship to aging and Scn5a disruption. These demonstrate that Nav1.5 was downregulated with both the Scn5a ϩ/Ϫ and the aging conditions ( Figure 6A ). In contrast, there were 220% and 57% increases in Nav1.1 expression in young and old Scn5a ϩ/Ϫ mice, respectively, compared with young WT mice (Scn5a ϩ/Ϫ versus WT, Pϭ0.03) ( Figure 6A ), consistent with a compensation for the deficiency in Nav1.5. Figure 6 shows that 33 transcripts for all the remaining major voltage-gated K ϩ and Ca 2ϩ channels, connexins, and Ca 2ϩ -handling transcripts also were downregulated with age in both WT and Scn5a ϩ/Ϫ mice. These were:
1. Nav␤3, 1 of the Na ϩ channel regulatory subunits ( Figure  6A and 6B) 2. HCN1 and HCN2 but not the major SAN HCN subunit HCN4 ( Figure 6C Figure 6F ) (Transcription of a major ion channel for generating the SAN pacemaker potential, Cav1.3, was decreased by 55% and 73% in old WT and old Scn5a ϩ/Ϫ mice, respectively, compared to young WT mice. Transcription of NCX1, responsible for the Na ϩ -Ca 2ϩ exchanger, was decreased by 49% and 72% in old WT and Scn5a ϩ/Ϫ mice, respectively.) 5. CLC3, Cftr, Trpc3, and ATP1a1, among other ion channels and transporters ( Figure 6G ) 6. Gap junction channels where there was decreased expression of Cx40 but not of Cx43 and Cx45, the latter a major SAN gap junction channel ( Figure 6G ) 7. Tbx3, an identified crucial transcriptional factor controlling ion channel gene expression program and phenotype 22 in the SAN ( Figure 6H ).
Taking all ion channels into account, there was a significant decrease in overall ion channel gene expression related to aging (PϽ0.001) ( Figure 6I ). Overall, the abundance of ion channel gene expression in the young Scn5a ϩ/Ϫ mice tended to be greater than in young WT mice, whereas in the aged mice, the overall channel gene expression of old Scn5a ϩ/Ϫ Figure 4 . Characterization of remodeling of extracellular matrix in the sinoatrial node (SAN). A, Staining of collagen by picrosirius red in SAN sections from the 4 groups of mice (ϫ20). B, Immunostaining of vimentin for fibroblasts in SAN tissue sections (ϫ20). C, collage quantification (area of picrosirius redstained tissue expressed as a percentage of the field of view). Two-way ANOVA Pϭ0.002 for Scn5a ϩ/Ϫ versus WT mice and Pϭ0.04 for young versus old mice. D, Fibroblast quantification (area of vimentin staining expressed as a percentage of the field of view) (young WT, nϭ5; young Scn5a ϩ/Ϫ , nϭ4; old WT, nϭ5; old Scn5a ϩ/Ϫ mice, nϭ4). Two-way ANOVA Pϭ0.017 for Scn5a ϩ/Ϫ versus WT mice and PϽ0.001 for young versus old mice. Abbreviations as in Figure 1 .
mice was lower than in old WT mice. Furthermore, there was a significant interaction between the aging and Scn5a disruption, and ion channel expression generally was lowest in the old Scn5a ϩ/Ϫ mice (PϽ0.001) ( Figure 6I ).
Finally, there was an upregulation of expression of the ␤ 1 -adenergic receptor, central to cardiac adrenergic signaling, associated with Scn5a disruption (Scn5a ϩ/Ϫ versus WT, Pϭ0.04) ( Figure 6J ). However, neither aging nor Scn5a disruption affected ␤ 2 -adrenergic receptor or muscarinic M 2receptor transcripts.
Computer Simulations
The experimental results associated aging and Scn5a disruption not only with tissue degeneration (featured as TGF-␤ 1mediated fibrosis), but also with transcriptional alterations in a large range of ion channels at the mRNA level. Our final investigations explored the implications of these changes for cell excitation and its propagation between cells and the extent to which this would account for the experimental observations, and so, they provide possible underlying mechanisms for the phenomena observed.
First, SAN action potentials in young WT mice were simulated using a previously developed action potential model of a mouse SAN myocyte from Kharche et al 20 ( Figure  7A ). This model then led to similar simulations for the remaining groups of old WT and young and old Scn5a ϩ/Ϫ mice ( Figure 7A ). As shown in online-only Data Supplement Table 1 , to simulate the SAN action potential of the old WT mice and young and old Scn5a ϩ/Ϫ mice, the ionic conductance for each major ionic current in the Kharche et al model were modified on the basis of changes in ion channel expression at the mRNA level. These computations successfully replicated the observed changes in SAN CL obtained from the in vitro experiments ( Figure 3B) . Thus, the models that incorporated the alterations in ion channel expression replicated the experimentally observed slowed pacemaker activity, as evidenced in their predicting increased CLs in separating successive pacemaking action potentials in the young Scn5a ϩ/Ϫ , old WT, and old Scn5a ϩ/Ϫ mice ( Figure 7A and 7B). They similarly replicated experimental findings that the old mice showed the slowest pacemaker activity ( Figure  7A and 7B) .
Second, the atrial SAN cell coupling model successfully replicated the observed slowing of SAN conduction with aging and Scn5a disruption. Thus, explorations of the effect of reducing the junctional conductance g j between cells ( Figure 7C ) further demonstrated prolongations of conduction times most obvious in the old Scn5a ϩ/Ϫ mice. Decreases of g j to Ϸ1.2 nanosiemens replicated the experimental conduction pattern in which SAN-atrial conduction was slowed in the old WT and young Scn5a ϩ/Ϫ conditions compared to young WT mice, with the greatest slowing in old Scn5a ϩ/Ϫ mice ( Figure 7C and 2D ).
Discussion
The present studies explored the relationships between the pathogenesis of SND and aging and Scn5a disruption as well as the possible interactions between these factors using the Scn5a ϩ/Ϫ mouse model known to directly replicate Scn5a haploinsufficiency. 14 Our results suggest that both electric Figure 5 . Expression of fibrosis-regulating genes and its relationship to expression of Nav1.5. A, Relative abundance of mRNA as measured by real-time polymerase chain reaction. Fibrosis-regulatory genes TGF-␤ 1 and vimentin (Aa) and Nav1.5 (Ab) are shown. Two-way ANOVA (nϭ5 in each group) Pϭ0.005 for TGF-␤ 1 , Pϭ0.008 for vimentin, and Pϭ0.02 for Nav1.5 in Scn5a ϩ/Ϫ versus WT mice and Pϭ0.005 for TGF-␤ 1 , Pϭ0.001 for vimentin, and Pϭ0.005 for Nav1.5 in young versus old mice. The aging and Scn5a disruption effects on TGF-␤ 1 and vimentin interacted with each other (Pϭ0.02 and Pϭ0.003, respectively). B, Correlations between gene expression of Nav1.5 and TGF-␤ 1 (R 2 ϭ0.77, PϽ0.001, nonlinear regression), Nav1.5 and vimentin (R 2 ϭ0.78, PϽ0.001, nonlinear regression), and TGF-␤ 1 and vimentin (R 2 ϭ0.85, PϽ0.001, linear regression). C, TGF-␤ 1 gene expression initiated by Nav1.5 inhibition with Nav1.5 antibody (control group, nϭ6; antibody-treated group, nϭ6). TGF-␤ 1 gene expression was increased by Nav1.5 antibody treatment at the transcriptional level (Ca) and at the protein level (Cb) in both human neonatal myocytes and fibroblasts, Student t test Pϭ0.04 for myocytes and Pϭ0.03 for fibroblast at transcription level and PϽ0.001 at protein level for antibody treated versus control. TGF-␤ 1 indicates transforming growth factor ␤ 1 . Other abbreviations as in Figure 1. remodeling and tissue degeneration, detected as TGF-␤ 1mediated fibrosis, affect pacemaker and conduction function in SND associated with Scn5a disruption or aging, with a combination of both aging and Scn5a disruption producing the most severe phenotype. In implicating Nav1.5 deficiency in such changes, we also suggest a novel regulatory role for Nav1.5 in cellular biological processes extending beyond its electrophysiologic function. Finally, the modeling studies at least partially reconstructed the physiological mechanisms by which both aging and Scn5a disruption lead to SND, thereby Figure 6 . Relative abundance of mRNA as measured by real-time polymerase chain reaction for ion channels and regulatory genes (nϭ5 for each group). Expression of Na ϩ channel subunits (A and B) , HCN channel subunits (C), K ϩ channel subunits (D and E), Ca 2ϩ channels subunits and Ca 2ϩ -handling proteins (F), other ion channels and gap junction channels (G), transcription factor Tbx-3 (H), all genes pooled together (I), and ␤ 1 -adrenergic receptor (J). Data are expressed as 2 Ϫ⌬Ct (versus reference gene Hprt) normalized by the mean value for young WT mice. Two-way ANOVA Pϭ0.02 for Nav1.5 and Pϭ0.04 for ␤ 1 -adrenergic receptor, Pϭ0.03 for Nav1.1 in Scn5a ϩ/Ϫ versus WT mice, Pϭ0.005 for Nav1.5 in young versus old mice, PϽ0.05 for all the genes in figures except for Nav1.1 and ␤ 1 -adrenergic receptor, and PϽ0.001 for all genes pooled together in old versus young mice. Aging and Scn5a ϩ/Ϫ interaction PϽ0.001 for all genes pooled together. Ct indicates cycle threshold; remaining abbreviations as in Figure 1 . . C and D, Simulation of sinoatrial conduction by SAN cell and atrial coupling. The coupling conductance (g j ) between sinus node and atrial cell obtained from connexins was varied in different simulations, and the conduction time is plotted against g j (C). Sinoatrial conduction time in the simulation (based on the young WT mice) when g j was 1.2 nS and its comparison to experimental data of sinoatrial conduction time (D). AP indicates action potential. Other abbreviations as in Figure 1 . drawing parallels between these and similar conduction changes in the ventricle that occur in the possibly related condition of PCCD.
Our physiological studies first demonstrated that aging and Scn5a disruption affected in vivo heart electrophysiological properties. Thus, Scn5a disruption significantly increased P-wave durations; RR, PR, and QRS intervals; and SAN recovery times. Aging did not exert effects in such in vivo recordings in intact animals, which could be due to autonomic alterations known to increase sympathetic activation with age as has been observed in humans. 23, 24 Interacting effects of aging and Scn5a disruption were observed in Poincaré plots representing HRV (Figure 2) . Such HRV alterations are considered critically predictive of cardiac arrhythmic events in the form of ventricular tachycardia and sudden cardiac death. 25, 26 In live animals, HRV results from cyclic inputs from the autonomic nerves acting on the SAN. Consistent with previous studies, 27 we demonstrated that HRV decreases with aging. We also associate for the first time to our knowledge decreases in HRV with Scn5a disruption. Scn5a gene disruption but not aging led to a marked upregulation of ␤ 1 -adenergic receptor transcript levels, further implicating alterations in autonomic function associated with the Scn5a gene disruption. 28 However, the Nav1.5 downregulation also might be involved in both aging-and Scn5a gene disruption-related HRV alteration. Therefore, the greatest decrease in HRV was observed in old Scn5a ϩ/Ϫ mice, which showed the lowest Nav1.5 expression.
Our results indicate that both aging and Scn5a disruption affected the intrinsic electrophysiological properties of the SAN itself. Thus, they exerted both individual and interacting effects in increasing CL and SACT in ex vivo SAN preparations isolated from their autonomic inputs. These alterations in turn correlated with corresponding alterations in fibrotic processes and ion channel and regulatory gene transcriptional remodeling.
Of these, the alterations in fibrotic processes directly parallel previous reports demonstrating an association between the Scn5a ϩ/Ϫ condition and ventricular fibrotic changes 15, 16 as well as a link between age-dependent SAN dysfunction and fibrosis, 29 although such features were not observed in all studies. 5, 30 Our present findings associated both Scn5a disruption and aging with fibrosis in the SAN. Thus, they demonstrated significant positive interacting effects of Scn5a disruption and age on collagen and fibroblast levels, with the greatest effects seen in the old Scn5a ϩ/Ϫ hearts. The resulting fibrosis could potentially slow conduction both within the SAN and from the SAN to the surrounding atrium. Aging and Scn5a disruption correspondingly resulted in interacting upregulatory effects on levels of the key modulator of fibrosis TGF-␤ 1 and the fibroblast marker vimentin, similarly showing maximal effects in the old Scn5a ϩ/Ϫ hearts. Altered expression of TGF-␤ 1 and vimentin transcripts is associated with increased collagen and fibroblast abundance, indicating that interstitial fibrosis occurred.
Further experiments implicated Nav1.5 deficiency in the underlying mechanism for these findings and provided a possible causal link between Nav1.5 deficiency and increased fibrosis in the SAN. Both Scn5a disruption and aging exerted strong downregulatory effects on Nav1.5 expression levels, giving the following order: old Scn5a ϩ/Ϫ Ͻold WTϽyoung Scn5a ϩ/Ϫ Ͻyoung WT. This finding provided a range of Nav1.5 expression levels against which measurements of TGF-␤ 1 and vimentin expression levels could be compared. The latter revealed strong negative correlations between the expressions of TGF-␤ 1 and vimentin and the expression of Nav1.5. Further in vitro experiments indicated that Na ϩ channel inhibition by either Nav1.5-E3 antibody or Na channel blocker significantly increased TGF-␤ 1 production by both cardiac myocytes and cardiac fibroblasts; previous studies have reported that both cell types normally express Nav1.5 and secrete TGF-␤ 1 . 31 Although the detailed mechanistic link needs further investigation, our results suggest that at least 2 potential mechanisms may underlie the Nav1.5deficiency-associated TGF-␤ 1 -mediated SAN fibrosis. First, TGF-␤1-dependent signaling can be regulated by Na channel activity. Our results show that increased TGF-␤ 1 mRNA/ active form TGF-␤ 1 protein in Nav1.5-E3 antibody-treated myocytes is associated with a significant reduction (50%) in i Na current density (online-only Data Supplement Figure 3 ). Such a result is consistent with the previous study by Ugarte and Brandan 32 in rat primary myotubes. These authors showed that the inhibition of electric activity by Na channel blocker upregulated TGF-␤ activity. In contrast, the promotion of electrophysiologic activity in myotube cultures induced by the upregulation of voltage-dependent Na channels or by direct stimulation with extracellular electrodes downregulated TGF-␤ activity in rat primary myotubes. Similar results also were obtained in denervated adult muscles. 33 The altered i Na channel activity may affect the intracellular environment, such as pH, which has been shown to activate TGF-␤ signaling.
Second, through its interacting proteins, Nav1.5 deficiency leads to activation of TGF-␤ 1 signaling activation, which is consistent with suggestions that Nav1.5 forms multiprotein complexes with Nav1.5-interacting proteins 34, 35 through which Nav1.5 may exert a regulatory role in cellular biological processes beyond its electrophysiologic function. The decreased Nav1.5 channel expression (online-only Data Supplement Figure 3 ) or altered configuration of channel complex could potentially underlie such mechanisms. Thus, the present findings should promote further investigations into the causal relationship between Nav1.5 channel deficiency and activation of TGF-␤ 1 signaling.
The second major finding bearing on the mechanisms underlying the electrophysiological changes concerns alterations in expression of a wide range of ion channels and regulatory genes in the SAN associated with aging and Scn5a disruption. There was reduced Nav1.5 expression not only with Scn5a disruption, but also with age. A further reduction in Nav1.5 in the SANs of aged mice indicates that aging impairs Nav1.5 expression in the SAN as an independent factor. Such an effect may account for the phenotypic variability of Nav1.5-defect-associated SND. In a recent study reported by Yanni et al, 7 a lack of the expression of Nav1.5 in old rat SAN manifested in a significant decline in sinus rate and slow sinoatrial conduction. Such age-related reduction in expression of Nav1.5 could help to explain the increase in the SAN conduction time observed in elderly patients and SAN exit block in sick sinus syndrome. In addition, aging but not the Scn5a disruption produced a wide range of downregulatory effects on ion channels. These findings took place along with a reduction in expression of the crucial transcription factor Tbx3 that is known to regulate the pacemaker gene expression program in the SAN, 22 suggesting a mechanism for the observed ion channel downregulation in the SAN.
Some of the additional ion channel changes also could be related to the observed physiological changes. Thus, downregulation of the regulatory Na ϩ channel subunit Nav␤3 (Ϸ70%) could affect the SND phenotype. The observed downregulation of Ca 2ϩ channel and Ca 2ϩ -handling protein transcripts ( Figure 6F ) was consistent with previous reports of age-dependent L-type Ca 2ϩ channel deficiencies in the SAN correlating with SND in aged guinea pig hearts. 6 The downregulation of key Kv4.2, KvLQT1, Meag, and Kv1.5 K ϩ channel transcripts would be expected to prolong pacemaker action potential repolarization and potentially contribute to sinus bradycardia or arrhythmias in SND. Finally, reduced Cx40, but not Cx43 and Cx45, together with decreased Na ϩ current and fibrosis, could slow conduction within the SAN and from SAN to the surrounding atrium. Our computer simulations indeed demonstrated that the ion channel remodeling resulted in slowed pacemaker activity and increased the SAN-atrium conduction time after aging and Scn5a disruption and, thereby, could contribute to a mechanism for our observations.
In conclusion, the present study demonstrates for the first time to our knowledge that both aging and Scn5a disruption contribute to the pathogenesis and severity of SND through mechanisms involving TGF-␤ 1 -mediated fibrosis associated with Na ϩ channel deficiency accompanied by transcriptional remodeling of ion channels. These findings also have important implications for possible mechanisms underlying other arrhythmic syndromes associated with Nav1.5 haploinsufficiency, such as PCCD and Brugada syndrome. These also are associated with degenerative fibrotic cardiac abnormalities that depend on age. 10, 12, 13 The present findings, therefore, will prompt future investigations in the Scn5a ϩ/Ϫ and other model systems further investigating the mechanisms underlying the alterations in the fibrotic regulatory pathway suggested here as well as the extent to which these are specific to the SAN or can be generalized to myocardial or conduction system components in the rest of the heart. Such clarifications will have important implications in their application to the development of future management strategies for these disease conditions.
